Nihon Kohden Corporation
General ticker "NHNKF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $2.2B (TTM average)
Nihon Kohden Corporation does not follow the US Stock Market performance with the rate: -32.1%.
Estimated limits based on current volatility of 0.0%: low 9.80$, high 9.80$
Factors to consider:
- Earnings expected soon, date: 2026-11-10 amc
- Company pays dividends (annually): last record date 2026-09-30, amount 0.10$ (Y1.02%)
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [11.78$, 18.15$]
- 2026-03-31 to 2027-03-31 estimated range: [11.95$, 18.47$]
Financial Metrics affecting the NHNKF estimates:
- Positive: with PPE of 27.4 at the end of fiscal year the price was neutral
- Positive: 7.80 < Operating profit margin, % of 9.19
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 1.36 <= 4.02
- Positive: 2.37 < Operating cash flow per share per price, % of 4.07
- Positive: -7.11 < Investing cash flow per share per price, % of -6.70
- Positive: -51.61 < Industry operating profit margin (median), % of -38.22
- Positive: Interest expense per share per price, % of 0.04 <= 0.07
- Negative: Return on assets ratio (scaled to [-100,100]) of 5.18 <= 7.19
- Negative: Industry earnings per price (median), % of -6.85 <= 0
Short-term NHNKF quotes
Long-term NHNKF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥206,603.00MM | ¥221,986.00MM | ¥225,424.00MM |
| Operating Expenses | ¥185,483.00MM | ¥202,394.00MM | ¥204,711.00MM |
| Operating Income | ¥21,120.00MM | ¥19,592.00MM | ¥20,713.00MM |
| Non-Operating Income | ¥3,596.00MM | ¥9,777.00MM | ¥857.00MM |
| Interest Expense | ¥10.00MM | ¥24.00MM | ¥144.00MM |
| R&D Expense | ¥6,200.00MM | ¥6,996.00MM | ¥0.00MM |
| Income(Loss) | ¥24,716.00MM | ¥29,369.00MM | ¥21,570.00MM |
| Taxes | ¥0.00MM | ¥12,342.00MM | ¥7,471.00MM |
| Net Income(Loss)* | ¥17,110.00MM | ¥17,026.00MM | ¥14,098.00MM |
| Stockholders Equity | ¥167,602.00MM | ¥181,082.00MM | ¥179,550.00MM |
| Inventory | ¥58,788.00MM | ¥57,786.00MM | ¥56,173.00MM |
| Assets | ¥216,728.00MM | ¥233,233.00MM | ¥258,276.00MM |
| Operating Cash Flow | ¥-2,513.00MM | ¥15,607.00MM | ¥15,286.00MM |
| Capital expenditure | ¥8,256.00MM | ¥4,786.00MM | ¥8,709.00MM |
| Investing Cash Flow | ¥-7,647.00MM | ¥-5,208.00MM | ¥-25,138.00MM |
| Financing Cash Flow | ¥-7,485.00MM | ¥-6,968.00MM | ¥2,550.00MM |
| Earnings Per Share** | ¥203.28 | ¥101.23 | ¥84.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.